Publication | Closed Access

In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates

Vitro Comparative ActivityHealth SciencesAntimicrobial SusceptibilityMedicineKlebsiella PneumoniaeAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyInfection ControlMetallo-beta-lactamase-producing Clinical IsolatesPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug Resistance